Jason M. Hollar - 18 Aug 2026 Form 4 Insider Report for CARDINAL HEALTH INC (CAH)

Reporting relationship: Chief Executive Officer
Issuer ticker: CAH
Reported as of: 18 Aug 2026
Net transaction value: -$29,375,516
SEC form: 4
Accepted by SEC: 20 Aug 2026, 07:33:33 UTC
Prior SEC filing: 18 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Amanda S. Pashi, Attorney-in-fact

Key filing fact

Jason M. Hollar filed Form 4 for CARDINAL HEALTH INC (CAH) on 20 Aug 2026.

Key facts

This page summarizes Jason M. Hollar's Form 4 filing for CARDINAL HEALTH INC (CAH).
10 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 20 Aug 2026, 07:33.

Change

Previous filing in this sequence was filed on 18 Aug 2026.
Current net transaction value: -$29,375,516.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001687858 Primary reporting owner

Hollar Jason M.

Relationship: Chief Executive Officer
Address: 7000 CARDINAL PLACE, DUBLIN
Signature: /s/ Amanda S. Pashi, Attorney-in-fact
Signature date: 20 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAH transaction

Common Shares

Sale

Transaction value: $5,021,226
Shares: -21,407
Change %: -6.8%
Price: $234.56
Shares after: 293,725
Date: 18 Aug 2026
Ownership: Direct
Footnotes: F1

CAH transaction

Common Shares

Sale

Transaction value: $7,045,282
Shares: -29,915
Change %: -10%
Price: $235.51
Shares after: 263,810
Date: 18 Aug 2026
Ownership: Direct
Footnotes: F2

CAH transaction

Common Shares

Sale

Transaction value: $3,833,840
Shares: -16,208
Change %: -6.1%
Price: $236.54
Shares after: 247,602
Date: 18 Aug 2026
Ownership: Direct
Footnotes: F3

CAH transaction

Common Shares

Sale

Transaction value: $2,958,508
Shares: -12,470
Change %: -5%
Price: $237.25
Shares after: 235,132
Date: 18 Aug 2026
Ownership: Direct
Footnotes: F4

CAH transaction

Common Shares

Sale

Transaction value: $1,447,363
Shares: -6,206
Change %: -2.6%
Price: $233.22
Shares after: 228,926
Date: 19 Aug 2026
Ownership: Direct
Footnotes: F5

CAH transaction

Common Shares

Sale

Transaction value: $809,941
Shares: -3,457
Change %: -1.5%
Price: $234.29
Shares after: 225,469
Date: 19 Aug 2026
Ownership: Direct
Footnotes: F6

CAH transaction

Common Shares

Sale

Transaction value: $1,342,379
Shares: -5,704
Change %: -2.5%
Price: $235.34
Shares after: 219,765
Date: 19 Aug 2026
Ownership: Direct
Footnotes: F7

CAH transaction

Common Shares

Sale

Transaction value: $1,591,612
Shares: -6,731
Change %: -3.1%
Price: $236.46
Shares after: 213,034
Date: 19 Aug 2026
Ownership: Direct
Footnotes: F8

CAH transaction

Common Shares

Sale

Transaction value: $3,840,042
Shares: -16,187
Change %: -7.6%
Price: $237.23
Shares after: 196,847
Date: 19 Aug 2026
Ownership: Direct
Footnotes: F9

CAH transaction

Common Shares

Sale

Transaction value: $1,485,323
Shares: -6,244
Change %: -3.2%
Price: $237.88
Shares after: 190,603
Date: 19 Aug 2026
Ownership: Direct
Footnotes: F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1-10 to this Form 4.

Footnote F2

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.07 to $236.065, inclusive.

Footnote F3

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.07 to $237.05, inclusive.

Footnote F4

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.08 to $237.67, inclusive.

Footnote F5

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.75 to $233.74, inclusive.

Footnote F6

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.75 to $234.735, inclusive.

Footnote F7

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.77 to $235.59, inclusive.

Footnote F8

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.77 to $236.765, inclusive.

Footnote F9

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.77 to $237.735, inclusive.

Footnote F10

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.86 to $238.065, inclusive.